Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Current Deferred Revenue (2017 - 2021)

Catheter Precision (VTAK) has disclosed Current Deferred Revenue for 5 consecutive years, with $1.8 million as the latest value for Q2 2021.

  • Quarterly Current Deferred Revenue fell 3.87% to $1.8 million in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Jun 2021, down 3.87% year-over-year, with the annual reading at $2.5 million for FY2020, 24.24% down from the prior year.
  • Current Deferred Revenue for Q2 2021 was $1.8 million at Catheter Precision, up from $1.8 million in the prior quarter.
  • The five-year high for Current Deferred Revenue was $3.3 million in Q4 2019, with the low at $1.7 million in Q4 2017.
  • Average Current Deferred Revenue over 5 years is $2.0 million, with a median of $1.9 million recorded in 2020.
  • The sharpest move saw Current Deferred Revenue skyrocketed 91.53% in 2019, then decreased 24.24% in 2020.
  • Over 5 years, Current Deferred Revenue stood at $1.7 million in 2017, then rose by 0.53% to $1.7 million in 2018, then surged by 91.53% to $3.3 million in 2019, then fell by 24.24% to $2.5 million in 2020, then dropped by 28.52% to $1.8 million in 2021.
  • According to Business Quant data, Current Deferred Revenue over the past three periods came in at $1.8 million, $1.8 million, and $2.5 million for Q2 2021, Q1 2021, and Q4 2020 respectively.